Literature DB >> 25744112

A first study on the incidence and prevalence of IBD in Malaysia--results from the Kinta Valley IBD Epidemiology Study.

Ida Hilmi1, Fauziah Jaya2, Andrew Chua3, Wong Choon Heng4, Harjinder Singh5, Khean-Lee Goh6.   

Abstract

BACKGROUND: Inflammatory bowel disease [IBD] is known to be rare in the Asia Pacific region but epidemiological studies are scarce.
METHODS: Kinta Valley [Ipoh] was chosen as the sample population. Malaysia has a multiethnic population consisting of Malays, Chinese, and Indians. New cases over 2 years were prospectively captured as well as all known existing cases. Total numbers of the population as a whole and of each ethnic group were obtained. Incidence, prevalence, and mean incidence over two decades were then calculated.
RESULTS: There were 10 new cases of IBD diagnosed from April 2011 to April 2013. The crude incidence rates of IBD, ulcerative colitis [UC], and Crohn's disease[CD], respectively, were 0.68, 0.46, and 0.20 per 100,000 persons. The highest incidence was among the Indians, 1.91 compared with 0.35 and 0.63 per 100,000 persons among the Malays and the Chinese, respectively. The mean incidence of IBD has increased steadily from 0.07 to 0.69 per 100,000 person-years over the past two decades. The UC:CD ratio was 8:1 from 1990 to 2000 and 3.6:1 from 2000 to 2010. The prevalence rates of IBD, UC, and CD, respectively, were 9.24, 6.67, and 2.17 per 100,000 persons. The highest prevalence also was among the Indians: 24.91 compared with 7.00 and 6.90 per 100,000 persons among the Malay and Chinese races, respectively.
CONCLUSIONS: The incidence and prevalence rates of IBD are low in Malaysia but the incidence appears to be increasing and marked racial differences exist. As in other Asian countries, the incidence of CD is increasing at a more rapid rate relative to UC.
Copyright © 2015 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Asia; Epidemiology; incidence; inflammatory bowel disease; prevalence

Mesh:

Year:  2015        PMID: 25744112     DOI: 10.1093/ecco-jcc/jjv039

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  13 in total

Review 1.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

2.  Epidemiology: Rising in the East.

Authors:  Kelly Rae Chi
Journal:  Nature       Date:  2016-12-21       Impact factor: 49.962

Review 3.  Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.

Authors:  Alexa R Weingarden; Byron P Vaughn
Journal:  Gut Microbes       Date:  2017-02-10

Review 4.  Changing epidemiological trends of inflammatory bowel disease in Asia.

Authors:  Wee Khoon Ng; Sunny H Wong; Siew C Ng
Journal:  Intest Res       Date:  2016-04-27

5.  The fecal microbiota as a biomarker for disease activity in Crohn's disease.

Authors:  Danyta I Tedjo; Agnieszka Smolinska; Paul H Savelkoul; Ad A Masclee; Frederik J van Schooten; Marieke J Pierik; John Penders; Daisy M A E Jonkers
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

Review 6.  Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.

Authors:  Karen Dubois-Camacho; Payton A Ottum; Daniel Franco-Muñoz; Marjorie De la Fuente; Alejandro Torres-Riquelme; David Díaz-Jiménez; Mauricio Olivares-Morales; Gonzalo Astudillo; Rodrigo Quera; Marcela A Hermoso
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

7.  Quality indicators in pediatric colonoscopy in a low-volume center: Implications for training.

Authors:  Way-Seah Lee; Chun-Wei Tee; Zhong-Lin Koay; Tat-Seng Wong; Fatimah Zahraq; Hee-Wei Foo; Sik-Yong Ong; Shin-Yee Wong; Ruey-Terng Ng
Journal:  World J Gastroenterol       Date:  2018-03-07       Impact factor: 5.742

8.  A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.

Authors:  Norfilza Mohd Mokhtar; Khairul Najmi Muhammad Nawawi; Jaarvis Verasingam; Wong Zhiqin; Ismail Sagap; Zairul Azwan Mohd Azman; Luqman Mazlan; Hamzaini Abdul Hamid; Nur Yazmin Yaacob; Isa Mohamed Rose; Eden Low Ngah Den; Mah Suit Wan; Raja Affendi Raja Ali
Journal:  BMC Public Health       Date:  2019-06-13       Impact factor: 3.295

9.  Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study.

Authors:  Hsu-Heng Yen; Meng-Tzu Weng; Chien-Chih Tung; Yu-Ting Wang; Yuan Ting Chang; Chin-Hao Chang; Ming-Jium Shieh; Jau-Min Wong; Shu-Chen Wei
Journal:  Intest Res       Date:  2018-11-20

10.  Temporal trend of disease recognition, treatment paradigm, and clinical outcomes of Crohn disease in Thailand from 2000 through 2017: Is early use of thiopurines beneficial?

Authors:  Julajak Limsrivilai; Satimai Aniwan; Asawin Sudcharoen; Natapat Chaisidhivej; Piyaphan Prueksapanich; Nonthalee Pausawasdi; Phunchai Charatcharoenwitthaya; Supot Pongprasobchai; Sathaporn Manassatit
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.